Acute Erythroderma in a Patient Receiving TNF-α-Blocking Therapy for Hidradenitis Suppurativa

Tumor necrosis factor-α (TNF-α) normally binds to TNF-α receptors, leading to the inflammatory response of autoimmune diseases. Adalimumab is a TNF-inhibiting, anti-inflammatory, biological medication which binds to TNF-α, thus reducing this inflammatory response. The use of TNF-α-inhibiting medicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Benhadou, Farida, Hellgren, Guillaume, Willaert, Fabienne, del Marmol, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836174/
https://www.ncbi.nlm.nih.gov/pubmed/29515388
http://dx.doi.org/10.1159/000485911

Ejemplares similares

Ejemplares similares